Biogaia

Biogaia Receivables

The Accounts Receivable of Biogaia (BIOG B.ST) as of Nov 21, 2026 is 190.13 M SEK. In the previous year, Accounts Receivable was 106.23 M SEK — a change of 78.98% (higher).

Receivables

190.13 MSEK

YoY

78.98%

Last updated:

Accounts Receivable of Biogaia is 2024 190.13 M SEK. Accounts Receivable of Biogaia was 2023 106.23 M SEK. It decreases by 78.98% higher compared to the previous year.

The Biogaia Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
96.83 M SEK
Jan 1, 2018
142.01 M SEK
Jan 1, 2019
129.76 M SEK
Jan 1, 2020
101.66 M SEK
Jan 1, 2021
128.15 M SEK
Jan 1, 2022
131.05 M SEK
Jan 1, 2023
106.23 M SEK
Jan 1, 2024
190.13 M SEK
The Biogaia Receivables history
YEARReceivablesYoY
190.13 MSEK+78.98%
106.23 MSEK-18.94%
131.05 MSEK+2.26%
128.15 MSEK+26.06%
101.66 MSEK-21.66%
129.76 MSEK-8.62%
142.01 MSEK+46.66%
96.83 MSEK+5.02%
92.21 MSEK+23.01%
74.96 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Accounts Receivable of Biogaia is 190.13 M SEK in 2024.

Accounts Receivable of Biogaia changed from 106.23 M SEK to 190.13 M SEK, representing a 78.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Biogaia since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Biogaia historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biogaia

All Key Metrics — Biogaia